SR-4370

CAS No. 1816294-67-3

SR-4370( SR-4370 | SR 4370 | SR4370 )

Catalog No. M17385 CAS No. 1816294-67-3

SR-?4370 is an HDAC inhibitor. SR-?4370 exhibited IC50 values of 0.5 μM, 0.1 μM and 0.06 μM towards HDAC1, HDAC2 and HDAC3.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 61 In Stock
5MG 102 In Stock
10MG 177 In Stock
25MG 332 In Stock
50MG 500 In Stock
100MG 705 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SR-4370
  • Note
    Research use only, not for human use.
  • Brief Description
    SR-?4370 is an HDAC inhibitor. SR-?4370 exhibited IC50 values of 0.5 μM, 0.1 μM and 0.06 μM towards HDAC1, HDAC2 and HDAC3.
  • Description
    SR-?4370 is an HDAC inhibitor. SR-?4370 exhibited IC50 values of 0.5 μM, 0.1 μM and 0.06 μM towards HDAC1, HDAC2 and HDAC3, resp. SR-?4370 is reported in WO 2015153516.
  • In Vitro
    SR-4370 is an inhibitor of HDAC, with IC50s of 0.13 μM, 0.58 μM, 0.006 μM, 2.3 μM, and 3.4 μM for HDAC1, HDAC2, HDAC3, HDAC8, and HDAC6, respectively. SR-4370 is cytotoxic to the breast cancer cells (MDA-MB-231), with an IC50 of 12.6 μM.
  • In Vivo
    ——
  • Synonyms
    SR-4370 | SR 4370 | SR4370
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    HDAC1| HDAC2| HDAC3
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1816294-67-3
  • Formula Weight
    304.34
  • Molecular Formula
    C17H18F2N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 150 mg/mL; 492.89 mM
  • SMILES
    Fc1c(cccc1F)c2ccc(cc2)C(=O)NNCCCC
  • Chemical Name
    N'-butyl-2',3'-difluoro-[1,1'-biphenyl]-4-carbohydrazide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. D Liao, etal. HDAC Inhibitor Compounds and Methods of Treatment
molnova catalog
related products
  • P2Y2R/GPR17 antagoni...

    P2Y2R/GPR17 antagonist 1 (Compound 14m) is a dual antagonist with an IC50 of 3.17 μM for P2Y2R and 1.67 μM for GPR17.

  • AR 231453

    AR 231453 is a selective and orally available GPR119 agonistcan stimulate β-cell replication and improve islet graft function.

  • Azathioprine

    Azathioprine is an immunosuppressive drug, inhibiting purine synthesis and GTP-binding protein Rac1 activation, used in the treatment of organ transplantation and autoimmune diseases.